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1. Introduction 
Tuberculosis (TB) is a threat to worldwide public health, mainly caused by Mycobacterium 
tuberculosis (M.tb.) bacteria species. Despite the availability of effective treatment, 
tuberculosis is responsible for more than three million deaths annually worldwide. The high 
susceptibility of human immunodeficiency virus-infected persons to the disease (Nunn et 
al., 2005), the emergence of multi-drug-resistant (MDR-TB) strains (Rastogi et al., 1992, 
Kochi et al., 1993; Bloch et al., 1994) and extensively drug-resistant (XDR-TB) ones have 
brought this infectious disease into the focus of urgent scientific interest. For this reason, 
there is a growing need and urgency to discover new classes of chemical compounds acting 
with different mechanisms from those currently used. Cinnamic acid (1; Fig. 1) and 
derivatives have a century-old history as antituberculosis agents. For example, gradual 
improvement was observed when the TB-patients were treated with cinnamic acid (1) 
prepared from storax (Warbasse, 1894). Furthermore, in 1920s, ethylcinnamate (2) (Jacobson, 
1919), sodium cinnamate (3) (Corper et al., 1920) and benzylcinnamate (4) (Gainsborough, 
1928) were reported to be efficacious in the treatment of TB (Fig. 1). Nevertheless, we feel 
that this class of molecules remained underutilized until recent years. Particularly in the last 
two decades, there has been huge attention towards various natural and unnatural cinnamic 
derivatives and their antituberculosis efficacy. This chapter provides a comprehensive 
literature compilation concerning the synthesis so as the antituberculosis potency of various 
cinnamic acid, cinnamaldehyde and chalcone derivatives. We envisage that our effort in this 
chapter contributes a much needed and timely addition to the literature of medicinal 
research.  
 
Fig. 1. Cinnamic acid, ethylcinnamate, sodium cinnamate and benzylcinnamate 
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2. Cinnamic acid derivatives as anti-TB agents 
trans-Cinnamic acid (1) has a long history of human use as a component of plant-derived 
scents and flavourings (Hoskins, 1984). It belongs to the class of auxin, which is recognized 
as plant hormones regulating cell growth and differentiation (Thimann, 1969). The 
cinnamoyl functionality is also present in a variety of secondary metabolites of 
phenylpropanoid biosynthetic origin. Those containing a sesquiterpenyl, monoterpenyl and 
isopentenyl chain attached to a 4-hydroxy group represent quite a rare group of natural 
products (Epifano et al., 2007). 
 
Fig. 2. Cinnamic acid and its natural phenolic-analogues 
The hydroxyl cinnamic acids such as p-coumaric acid (5), caffeic acid (6), ferulic acid (7), 
sinapic acid (8) (Fig. 2) are natural products arising from the deamination of the phenyl 
alanine (9) (Scheme 1) (Kroon & Williamson, 1999). Besides, they are important constituents 
in the biochemical pathway in plants leading to the lignin (Humphreys & Chapple, 2002; 
Boerjan et al., 2003), the second most abundant biopolymer after cellulose (Whetten et al., 
1998) resulting mainly from the oxidative polymerization (Freudenberg, 1959) of the three 
hydroxycinnamyl alcohols, namely coumaryl (10a), coniferyl (10b) and sinapyl alcohols 
(10c). These key cinnamyl alcohols are produced through two successive enzyme-catalyzed 
reductions starting from the corresponding cinnamyl SCoA-esters. In recent years, trans-
cinnamic acid derivatives have also attracted much attention due to their antioxidative 
(Chung & Shin, 2007), antitumor (De et al., 2011a) and antimicrobial (Naz et al., 2006; 
Carvalho et al., 2008) properties.  
 
Scheme 1. Lignin biosynthesis pathway 
2.1 Cinnamic acid 
In an attempt to develop a new strategy to circumvent MDR-TB by augmenting the 
potential of the existing drugs (Rastogi et al. 1994), trans-cinnamic acid (1) was used along 
with known antituberculous drugs such as isoniazid (11), rifampin (12), ofloxacine (13) or 
clofazimine (14) (Fig. 3). Interestingly, a synergistic increase was observed in the activity of 
various drugs against Mycobacterium avium. The synergistic activity of 1 (Rastogi et al. 1994) 
with a variety of drugs was manifested even with drug resistant isolates. Importantly, it was 
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proved that 1 is not bactericidal. The dose-dependent effect of cerulenin (16) and trans-
cinnamic acid on M.tb. viability showed (Rastogi et al. 1996) that cinnamic acid was not 
bactericidal even at concentrations as high as 200 µg/mL, whereas cerulenin was 
bactericidal only at concentrations above 50 µg/mL. 
 
Fig. 3. Known antituberculosis drugs 
 
Fig. 4. Known antibiotics used in synergy studies 
Thus, the sub minimum inhibitory concentrations (sub-MIC) of both 16 and 1 used in 
synergy experiments (fixed concentrations of only 1 µg/mL) were not due to any direct 
effect of these two inhibitors on tubercle bacilli (TB). Out of the various drug combinations 
screened, those with 1 gave the best results. For example, enhancement of drug activity 
was even observed with the drug-resistant strain 92-0492 (resistant to isoniazid (11) & 
rifampin (12)) when 1 at sub-MIC concentrations was used in combination with antibiotics 
such as ofloxacine (13), clofazimine (14) and amikacine (15). Cerulenin (16) is a known 
antifungal antibiotic that inhibits fatty acid and steroid biosynthesis. In fatty acid 
synthesis, 1 proved to bind in equimolar ratio to ǃ-keto-acyl-ACP synthase, one of the 
seven moieties of fatty acid synthase, blocking the interaction of malonyl-CoA (Nomura et 
al., 1972; Omura, 1976). It is therefore likely that the inhibitory effects that were observed 
in the synergy study resulted from the inhibition of fatty acid synthesis. However, the 
mode of action for 1 is still unknown. In a previous study with M. avium (Rastogi et al., 
1994), it was suspected that 1 might have inhibitory effects because of its structural 
similarity to phenylalanine. Because of that similarity, 1 would inhibit glycopeptidelipid 
(GPL) biosynthesis, therefore increasing cell wall permeability and enhancing the 
inhibitory effect of antimycobacterial drugs. As M.tb. does not synthesize GPL antigens, 
this reasoning does not fully fit with this bacterial species. Apparently other sites are also 
www.intechopen.com
 
Understanding Tuberculosis – New Approaches to Fighting Against Drug Resistance 
 
340 
being affected by 1, which in turn enhance the susceptibility of the organism to the effects 
of the antimycobacterial drugs. Although, trans-cinnamic acid (1) was used to treat 
tuberculosis before antimycobacterial chemotherapy was used (Ryan, 1992), this was the 
first example of MDR-TB activity in synergy with other drugs but the mechanism of 
action still remains unknown. 
2.2 Natural compounds  
In another context, a cinnamoyl ester was identified to be important in glycoside extracts of 
a native North American prairie plant named Ipomoea leptophylla. In fact, the organic soluble 
extracts from its leaves showed (Barnes et al. 2003) in vitro activity against M.tb. Through a 
bioassay-guided fractionation of these extracts, the authors isolated leptophyllin A (18), a 
resin glycoside bearing a trans-cinnamic residue attached to one rhamnose moiety (Fig. 5). 
This compound showed 13% inhibition at 6.25 µg/mL against M. tb. in the in vitro anti-TB 
assay. Furthermore, the bioassay results indicated that the cinnamic acid residue is required 
for the observed antimicrobial activity as an analogous compound bearing no cinnamic acid 
residue, leptophyllin B (19), also isolated from the same source, showed no in vitro activity. 
Recently, some bioactive styryllactones and alkaloids were isolated from flowers of 
Goniothalamus laoticus (Lekphrom et al. 2009). In particular, the authors isolated a 
styryllactone derivative, namely howiinin A (20), by fractionation of the ethyl acetate and 
methanol extracts from the flowers of this species (Fig. 6). While inactive against Plasmodium 
falciparum, this compound possessing a cinnamoyl ester moiety showed an interesting anti-
TB activity (MIC = 6.25 µg/mL) when tested against M.tb. strain H37Ra. 
 
Fig. 5. Resin glycosides from I. Leptophylla 
 
Fig. 6. Structure of Howiinin A  
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2.3 Synthetic compounds 
2.3.1 Cinnamic ester derivatives 
It is well known that triterpenes exhibit moderate to high in vitro antimycobacterial activity 
against M. tb. (Copp & Pearce, 2007; Okunade, Elvin-Lewis & Lewis, 2004). The modification 
of natural triterpenes such as betulinic acid (21), oleanolic acid (22) and ursolic acid (23) 
through introduction of cinnamoyl frames at the C-3 position has been reported (Scheme 2) 
(Tanachatchairatana et al., 2008). Different cinnamoyl derivatives such as cinnamate, p-
coumarate, ferulate, caffeate and p-chlorocinnamate esters of the above mentioned 
triterpenes were synthesized by reacting with the suitable cinnamoyl chlorides in the 
presence of 4-N,N-dimethylaminopyridine (DMAP) in benzene. All the hydroxyl-cinnamic 
acids were acetylated to protect the phenolic group before generating the corresponding 
acid chlorides followed by coupling with the triterpenes. The hydroxycinnamate derivatives 
of the triterpenes (21d,f,h; 22d,f,h; 23d,f,h) were easily obtained by deacetylation of the 
acetylated derivatives (21c,e,g; 22c,e,g; 23c,e,g) using K2CO3 in methanol. The biological 
results indicated that the introduction of unsubstituted or p-chlorinated cinnamate ester 
functionality (21a,b; 22a,b; 23a,b) led to inactive compounds (MIC>200 µg/mL) or without 
any improvement in the antimycobacterial activity of the native triterpenes. Interestingly, 
the results also indicated that introduction of the p-coumarate moiety at the C-3 position of 
the triterpenes (21d, 22d, 23d) resulted in an 8-fold increase in antimycobacterial activity of 
the parent triterpenes 21 (MIC = 50 µg/mL) and 22 (MIC = 50 µg/mL), and a 2-fold increase 
in the activity of the triterpene 23 (MIC = 12.5 µg/mL). Introduction of a ferulate moiety 
(21h, 22h, 23h) resulted in a 4-fold increase in activity only in case of 23. However, the 
presence of a p-hydroxy group plays a crucial role on the high antimycobacterial activity 
because its methylation and acetylation proved to decrease antimycobacterial activity in a 
significant manner, caffeate esters 21e,g and 22e,g being the exceptions. 
 
Scheme 2. Cinnamate-based triterpenes and their biological activities  
2.3.2 Cinnamic amide derivatives  
Rifampin (RIF; 12; Fig. 3) is one of the most important drugs in TB treatment. In search for 
new compounds with structural modifications of existing lead drugs, the presence of a 
cinnamoyl moiety on rifampin's piperazinyl framework instead of a methyl group, 
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furnishing 3-(4-cinnamylpiperazinyl-iminomethyl)rifamycin derivative (24; rifamycin SV 
(T9); Fig. 7), resulted in enhanced antimycobacterial activity (Reddy et al. 1995; Velichka et 
al. 2010). The antimycobacterial activities of 24 on 20 susceptible and MDR-strains of M.tb. 
and 20 M. avium complex (MAC) strains were investigated (Dimova et al. 2010). The 
radiometric MICs of T9 for M.tb. were significantly lower than those of RIF. The MICs of T9 
and RIF at which 90% of the RIF-susceptible strains were inhibited were <0.25 and <0.5 
µg/mL, respectively. Compound 24 had better activity against MAC strains, and the MIC at 
which 90% of the MAC strains were inhibited was <0.125 µg/mL, while that of RIF was <2.0 
µg/mL. Compound 24 also showed high in vitro bactericidal and intracellular activities 
which were significantly superior to those of RIF against both M.tb. and MAC strains. More 
importantly, 24 showed excellent in vivo activity against M.tb. H37Rv compared to RIF in 
both the lungs and spleens of C57BL/6 mice, indicating the potential therapeutic value of 24 
in the treatment of mycobacterial infections. 
 
Fig. 7. Structure of Rifamycin SV(T9)  
In an attempt to find novel compounds active against TB, a series of phenylacrylamides 
designed by molecular hybridization of trans-cinnamic acids and guanylhydrazones  were 
synthesized and antiTB efficacy were evaluated (Scheme 3) (Bairwa et al., 2010). While 
cinnamic acids are already known for their antituberculosis efficacy, guanylhydrazones 
have been shown to have antimicrobial activity including an interesting gram-negative 
bacterial endotoxin lipopolysaccharide (LPS) sequestering activity (Gadad et al. 2000; Wu 
et al. 2009). M. tb. contains lipoarabinomannan (LAM), a complex lipid glycoprotein 
anchored to the cell membrane by phosphatidylinositol which has structural and 
functional similarity to LPS, including the presence of anionic phosphate groups (Zhang 
et al., 1994). Biosynthesis of LAM is known to be a target for several antituberculosis 
agents, including the first line antitubercular agent, ethambutol (17; Fig. 4) (Scherman et 
al. 1995; Heijenoort, 2001). For the synthesis of the most active phenylacrylamide 
derivative (28; Scheme 3), the required guanylhydrazone (25a) was prepared by the 
microwave-assisted reaction of 3,4-dimethoxy benzaldehyde (25) with guanylhydrazine 
hydrochloride (26). In parallel, the phenyl 4-methoxycinnamate (27a) was prepared by 
esterification of 4-methoxycinnamic acid (27) via its treatment by phenol and thionyl 
chloride. Finally, the coupling of equimolar quantities of guanylhydrazone (25a) with 
phenylcinnamate (27a), was performed under microwave irradiation in the presence of 
triethylamine and ethanol as solvent to afford the target derivative (E)-N-(((E)-2-(3,4-
dimethoxybenzylidene)hydrazinyl)(imino)methyl)-3-(4-methoxyphenyl)acrylamide (28). 
Compound 28 was found to be active when tested on resazurin microtiter plate assay 
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(REMA) against M. tb. H37Rv (MIC = 6.5 µM) along with good safety profile (CC50 = 340 
µM) in VERO cell line. Importantly, analysis of structure–activity relationships revealed 
that both steric and electronic parameters play major role in the activity of this series of 
compounds. 
EtOH, MW, 60WH
O
H2N
NH NH2
NH .HCl
+
PhOH,  SOCl2
H
N
OH
O
OPh
O
H
N
28; MIC = 6.5 µM
25 25a
27a
Et3N, EtOH, MW, 
60W
26
MeO
OMe
MeO MeO
MeO
OMe
MeO
OMe
27
NH NH2
NH
NH NH
NH O
OMe
 
Scheme 3. Synthetic route for the synthesis of phenylacrylamide derivatives 
A series of 1-[(2,3-dichloroanilinomalonyl)-3-(N-2’-cyanoethyl)-2-(N-cinnamoyl) 2,3-Di-
chloroanilino)]-5-phenyl pyrazolines (38a-e) have been synthesized from N-cinnamoyl-N-
2’-cyanoethyl-2,3-dichloroaniline (37) in the presence of 2-[(N-cinnamoyl) 2,3-
dichloroanilido] acetohydrazides (33a-e) and acetic acid in dioxane (Scheme 4) (Sharma et 
al., 2010, 2011). These compounds have been tested for in vitro antitubercular activity on 
M.tb. H37Rv strains. 
The compounds (38a-e) inhibited the growth of M.tb. at 100 µg/mL concentration. The 
acylhydrazide (33a) was also coupled with some aromatic aldehydes (29a-c) in the presence 
of catalytic H2SO4 in ethanol. The resulting hydrazones (34a-c) were also found to have anti-
TB activity.  
Using a molecular hybridization approach, a series of cinnamide derivatives (39a-42a) was 
designed as potential antimycobacterial agents (Kakwani et al. 2011). The diamine moiety of 
ethambutol (17; Fig. 4) and its other analogs proved to be a key feature. Various diamines 
(39-42) were coupled with 1 using ethylchloroformate and triethylamine to obtain 
cinnamide derivatives (39a-42a) (Scheme 5). The MICs of all synthesized compounds were 
determined against M.tb. H37Rv using Resazurin Microtitre plate Assay (REMA) method. 
The synthesized molecules (39a-42a) showed good to moderate activities with MIC in the 
range of 5–150 μM and good safety profiles. The most potent compound 39a, having MIC of 
5.1 μM (cytotoxicity measured on VERO cells line C1008 (CC50) = 618 μM) exhibited synergy 
with rifampin (12). Under similar conditions ethambutol (17) showed MIC of 15.3 μM with a 
CC50 value of 1470 μM. 
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Scheme 4. Synthesis of cinnamoyl pyrazolines and analogs 
 
Scheme 5. Synthesis of cinnamides from diamines 
2.3.3 Cinnamic oxadiazole derivatives  
The synthesis of some 1,3,4-oxadiazoles and oxo-imidazolines compounds as potent 
biologically active agents has been reported (Joshi et al., 1997). The synthetic routes are 
presented in Scheme 6. The common precursor 44 was obtained through condensation of 5-
nitro-o-benzoylene-2,1-benzimidazole (43) with hydrazine hydrate. The cyclocondensation 
reaction of different aromatic acids with 44 in the presence of POCl3 afforded 1,3,4-
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oxadiazoles 45a-e. Compounds 45a-d were found to be more active against M.tb. H37Rv than 
the cinnamic derivative 45e at 12.5 µg/mL.   
 
Scheme 6. Synthesis of various 1,3,4-oxadiazoles and 5-oxo-imidazolines  
2.3.4 Cinnamic benzimidazole derivatives  
Benzimidazole scaffold being an important pharmacophore and privileged structure in 
medicinal chemistry (Khalafi-Nezhad et al., 2005; Evans et al. 1988), a new series of 5-
(nitro/bromo)-styryl-2-benzimidazoles (49a-f, 50a-f; Scheme 7) was  synthesized 
(Shingalapur et al., 2009) by simple condensation of 5-(nitro/bromo)-O-phenylenediamine 
(46, 47) with trans-cinnamic acids (48a-f) in ethylene glycol for 6 h at around 200°C (Scheme 
7). The in vitro anti-TB activities of compounds 49a-f and 50a-f on the M.tb. H37Rv were 
determined at 7.25 µg/mL concentration. Interestingly, the bromo-substituted 
benzimidazole derivatives (50a-f) exhibited the best results with 63-83% inhibition. 
 
Scheme 7. Synthesis of styryl-2-benzimidazoles series 
2.3.5 Cinnamic acid hydroxamic derivatives  
The sequestration of iron is a part of the non-specific mammalian immune response and 
thus, metal uptake and regulation of metal-ion concentrations are the key features of host-
pathogen interactions (Agranoff & Krishna, 2004). Siderophores are small, high-affinity 
iron chelating compounds secreted by microorganisms such as bacteria, fungi and grasses 
(Neilands, 1995; Cornelis & Andrews, 2010). Siderophores are considered amongst the 
strongest soluble Fe(III)-binding agents known. Siderophores, produced by mycobacteria 
itself, were used (Guo et al., 2002) to target iron transport processes essential for the 
growth and survival of M. tb. Targeting the iron transport processes of M.tb. is 
challenging for several reasons. The complexity of the mycobactin architecture itself poses 
a daunting synthetic challenge, which hampers the generation of conjugates (Xu & Miller, 
1998). Further, the iron transport mechanism involves an “iron-handoff” between two 
siderophore families, the exochelins and the mycobactins. In low iron environments, M.tb. 
biosynthesizes and secretes hydrophilic exochelins (e.g., Mycobactin J (51); Scheme 8) to 
bind exogenous ferric ion. The iron-complex is then transferred to intracellular 
siderophores (i.e. the mycobactins) which are lipophilic chelators associated with the 
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cytoplasmic membrane (Roosenberg et al., 2000). The mycobactin so-associated with iron 
either remains in the cell wall as an iron storage pool or is released into the cell by a 
mycobactin reductase. Therefore, the sequestration of the available iron into a form, 
which cannot be processed by M.tb. may be an alternative therapeutic way. The success of 
this approach relies on the understanding of the molecular recognition events involved in 
mycobacterial iron transport. In that context, the authors synthesized different iron 
chelators containing ǂ,ǃ-unsaturated hydroxamic acid motifs appended to a citric acid 
platform such as Nannochelin A (56b) and compared their activities with the 
corresponding trans-octenoyl derivative (56a). As shown in Scheme 8, the synthesis starts 
from diamines (52a,b) with a three-steps sequence to afford, after monoprotection, N-
benzoylation and N-acylation with trans-cinnamoyl chloride, the dissymetric amino-
compounds 53a,b. 53a,b were then treated with a 10% NH4OH solution in methanol 
solution at 0 °C to deprotect the hydroxamic acid and the resulting derivatives were 
treated with trifluoroacetic acid (TFA) to produce the TFA salts 54a,b. Finally, the 
condensation of 54a,b with the activated Boc-protected citric acid (55) in 1,4-dioxane 
followed by TFA treatment gave the desired chelators 56a,b. Notably, molecules that 
provided significantly higher growth index (GI) values than the native chelator 51 were 
identified as superior growth stimulants and more efficacious iron delivery agents. The 
systems containing longer tethers gave higher GI values (e.g., GI = 0.76 for 56a vs 1.5 for 
56b). It was envisaged by the authors that the longer tether allows for a more 
conformationally flexible ligand to properly coordinate to iron thus providing an increase 
in hydrophobicity. However, the authors identified 56b as a superior growth stimulant 
and a more efficacious iron delivery agent. Such ligands, which offer regulation of the 
initial iron delivery step, provide the opportunity to compare the iron transport 
mechanisms of both native and genetically modified mycobacteria. 
  
Scheme 8. Synthesis of Nannochelin A 
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2.3.6 Cinnamic acid hydrazide, thioester and other derivatives 
trans-Cinnamic acid hydrazide derivatives were presented as potential antituberculosis 
agents (Carvalho et al. 2008).  The authors designed and explored the introduction of the 
trans-cinnamic moiety into isoniazid (11) core structure to ameliorate its activity. Isosteric 
substitution of the pyridine ring of 11 was also investigated by these authors. The synthetic 
route (Scheme 9) used for the preparation of the target compounds is rapid and relies on the 
formation/use of p-nitrophenyl esters (58a-d) as activated forms of cinnamic acid 
derivatives (Scheme 9). These stable intermediates (58a-d) were prepared by treating the 
appropriate cinnamic acid (57a-d) with thionyl chloride in the presence of 4-nitro-phenol. 
The target hydrazides (11a-d, 59a-d; Scheme 9) were then obtained in good yields by 
coupling the so-formed activated acids (58a-d) with either acylhydrazide 11 or 59. The anti-
TB activities of these compounds were assessed against M.tb. Almost all of the isonicotinic 
derivatives 11a-d were sensitive in the minimum concentration tested (MIC = 3.12 µg/mL). 
Nevertheless, all benzoic acid derivatives 59a-d were much less active, thus reinforcing the 
pharmacophoric contribution of the isonicotinic moiety. Importantly, the authors identified 
that the 4-methoxycinnamic derivatives promote the better activity. 
 
Scheme 9. Synthetic route for the preparation of the cinnamoyl hydrazides 
In our recent effort, we have synthesized some 4-alkoxycinnamic acid thioesters, amides, 
hydrazides and triazolophthalazine derivatives (Yoya et al., 2009; De et al., 2011b) and 
evaluated their anti-TB efficacy (Scheme 10). While 4-alkoxy substitutions were introduced 
to control the required lipophilicity following Lipinski’s rules (Lipinski et al., 1997), their 
coupling partners were suitably chosen either to mimic biological intermediates or to 
modify any existing drug. Accordingly, various 4-alkoxycinnamic acids were coupled with 
N-acetylcysteamine (62) to afford the corresponding thioesters (62a,e,f) thereby mimicking 
the enoylacyl-ACP intermediate involved in the M.tb. fatty acid synthase II (FASII) cycle, an 
essential step towards mycolic acid (C26-C56 fatty acids) biosynthesis. Mycolic acids are 
essential components of bacterial cell wall and notably, isoniazid is known to inhibit InhA 
(enoylacylreductase A; involved in FAS II cycle) thereby inhibiting the mycolic acid 
biosynthesis. The major advantage of FAS II-cycle as drug target is that it is an exclusive 
feature of prokaryotes. However, the synthesized thioesters (62a,e,f) showed poor anti-TB 
activities against M.tb. H37Rv, possibly due to the weak C-S bond energy which makes these 
molecules labile under physiological conditions. No amide derivatives (63a,e, 64a,b,d,f; 
65a,e,f) showed good biological activity except (E)-N-(2-acetamidoethyl)-3-(4-
geranyloxyphenyl)acrylamide (63f) (MIC = 0.24 µM, vs INH; MIC = 0.6 µM). Unfortunately, 
they (63a,e, 64a,b,d,f; 65a,e,f) have poor cytotoxicity profile. To alleviate the concern for the 
proteolytic instability, we thus prepared a series of cinnamoylhydrazides (66a-f). All six 4-
alkoxycinnamoyl isonicotinyl hydrazides (66a-f) showed good MIC and their cytotoxicity 
profile (IC50 ranging between 43-256 μM on THP-1 cell line) were very much encouraging. 
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Further, the radio-thin-layer chromatography analysis of 52e, when introduced to the broth 
culture of M.tb., revealed that this class of molecules inhibit the mycolic acid biosynthesis. 
Two representative INH-derivatives 66a (same as 11b in Scheme 9) and 66e were tested on 
MYC5165, a M.tb. strain mutated in InhA and 1400 a M.tb. strain mutated in katG. The 
inhibitory activities of 66a (MIC = 16 µM: MYC5165; 320 µM: 1400) and 66e (MIC = 27 µM: 
MYC5165; 68 µM: 1400) were found to follow similar trends as that of INH (MIC = 18 µM: 
MYC5165; 729 µM: 1400) itself, thus not allowing at the moment to propose these 
compounds as isoniazid prodrugs or not. In order to explore the influence of other 
hydrazides, 1-hydrazinophthalazine hydrochloride 67, an antihypertensive drug (Schroeder, 
1952; Silas et al., 1982) of moderate potency, was coupled with acids 60a-f in the presence of 
EDC.HCl, HOBt and triethylamine to afford phthalazinohydrazides (67a-f). For the family 
of 1-phthalazinohydrazides (67a-f), MIC results were moderate but the trend of cytotoxic 
behaviour was not acceptable. Under different experimental conditions, coupling of acids 
(60a-f) with 67 in acetonitrile under reflux furnished the corresponding 3-(4-alkoxystyryl)-
[1,2,4]triazolo[3,4-]phthalazines (68a-f). Interestingly, the combination of isopentenyl-side 
chain as 4-alkoxy substituent with triazolophthalazine (68e), showed excellent 
antitubercular potency (MIC = 1.4 µM), in comparison with other derivatives in the series 
(68a-f), and more importantly, with good cytotoxicity (IC50 = 449 µM on THP-1 cell line) and 
selectivity index (SI = 320). Finally, to our great delight, compound 68e showed 100-fold 
better in vitro activity against MYC5165 strain (68e; MIC = 0.2 M) and 1800-fold better 
activity against 1400 strain (68e; MIC= 0.4 M) compared to INH. 
 
Scheme 10. Synthetic route for the preparation of different cinnamoyl derivatives  
Further, the radio-thin-layer chromatography analysis revealed that compound 68e does not 
inhibit mycolic acid biosynthesis signifying a different mode of action than INH.  In order to 
explore the importance of the enoyl-acyl backbone, the double bond was replaced by 
bioisosteric cyclopropyl moiety. Thus, 3-[2-(4-alkoxyphenyl)cyclopropyl]-[1,2,4]triazolo[3,4-
ǂ]phthalazine (69a-f; racemates) were synthesized and their in-vitro anti-TB activities were 
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also evaluated. Significantly, the MICs of the compounds (69a-f) were found to be poorer 
compared to 68a-f. In regard to the difference in activities between the enoyl and 
cyclopropyl series, a plausible explanation could be the respective Michael acceptor ability. 
From a chemical point of view, 4-OCF3 derivatives are expected to show better inhibitory 
activities compared to their 4-OCH3 analogues. However, this is not the case as 66a has a 4-
fold better activity (MIC = 0.3 µM) compared to 66b (MIC = 1.1 µM) and similarly 68a (MIC 
= 53 µM) exhibits approximately 15-fold activity better than 68b (702 µM). In view of these 
results, it was suggested that the Michael addition may not be the mode of action of these 
compounds. This view was also supported by the fact that mycobacterial lip B prefers to 
form thioester intermediate with deca-2-enoic acid during mycolic acid biosynthesis unlike 
E.coli lipB which forms a thioether via Michael addition (Ma et al.; 2006). 
3. Cinnamaldehyde derivatives as anti-TB agents  
Cinnamaldehyde (70), also biosynthesized starting from phenylalanine (9) in the process of 
lignin biosynthesis, occurs naturally in the bark of cinnamon trees and other species of the 
genus Cinnamomum. Owing to its typical odor and low toxicity to human exposure, 
cinnamaldehyde is used as food flavoring agent. It is also used as a fungicide, insecticide for 
mosquito larvae (Cheng et al., 2004) and has shown inhibitory activities towards 
proliferation, invasion and tumor growth in a murin A375 model of human melanoma 
(Cabello et al., 2009). Importantly, 70 and its derivatives have shown enormous potential as 
antimicrobial agents. For example, cinnamaldehyde is known to inhibit E. coli and Salmonella 
typhimurium growth (Helander et al., 1998). Its carbonyl group has affinity for proteins, 
preventing the action of decarboxylase amino acids on E. aerogenes (Wendakoon & 
Sakaguchi, 1995). From a chemical standpoint, worth precising is that 70 so as its 3-
phenylacrylaldehydic congeners offer three main reactive sites: substitution on the phenyl 
ring, addition on the ǂ,ǃ-unsaturation and reactions of the aldehyde functionality. The ǂ,ǃ-
unsaturated carbonyl moiety can be considered as a Michael acceptor (Chew et al., 2010), 
which is often employed in the design of drugs (Ahn & Sok, 1996).  
3.1 Cinnamaldehyde  
The growth of M. avium subsp. paratuberculosis is inhibited by cinnamaldehyde (70) with a 
MIC of 25.9 μg/mL (Wong et al., 2008). Importantly, the authors suggest that the 
mechanism of antimicrobial activity of naturally occurring compounds such as 
cinnamaldehyde is specific rather than nonspecific since it is concentration dependent 
(Friedman et al., 2002). Possible modes of action include disruption of cell membranes, 
inhibition of essential enzymes, chelation of essential trace elements (such as iron), and 
targeting of cell membranes. Cinnamaldehyde (70) is also known to inhibit the bacterial cell 
division protein FtsZ (Domadia et al., 2007). FtsZ, a prokaryotic homolog of tubulin, 
regulates cell by assembling into the macromolecular structure called Z-ring at the site of 
cell division (Romberg & Levin, 2003). While cinnamaldehyde (70) proves to decrease the in 
vitro assembly reaction and bundling of FtsZ, 70 was also found to perturb the Z-ring 
morphology in vivo and to reduce the frequency of the Z ring per unit cell length of 
Escherichia coli. In addition, GTP-dependent FtsZ polymerization is inhibited by 70, 
cinnamaldehyde (70) inhibiting the rate of GTP hydrolysis and binding FtsZ with an affinity 
constant of 1.0 ± 0.2 μM−1. Isothermal titration calorimetry revealed that the binding of 70 to 
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FtsZ is driven by favorable enthalpic interactions. This signifies that 70 binds FtsZ, perturbs 
the cytokinetic Z-ring formation and inhibits its assembly dynamics. The authors suggested 
that 70, a small molecule of plant origin, is a potential lead compound that can be developed 
as an anti-FtsZ agent towards drug design. 
3.2 Cinnamaldehyde-derived hydrazones 
The synthesis and antimycobacterial efficacy of a new class of styryl derivatives (74a-c) were 
reported (Scheme 11) (Biava et al., 1997). The desired styryl derivatives (74a-c) were 
prepared in a three-steps sequence that begins by the reduction of the starting nitro 
compounds (71a-c) furnishing ortho-, meta- or para-aminotoluidines possessing either an 
imidazole, pyrazine or morpholine frame (72a-c). The so-obtained compounds (72a-c) were 
then coupled under reductive amination conditions (Scheme 11) with cinnamaldehyde (70) 
to afford the toluidine-styryl derivatives (74a-c). Among all synthetized compounds, 
derivatives 73c (R=Imidazole) and 74a-c (R=Imidazole) were the most active against five 
different M.tb.  strains with MIC values ranging between 1 to 64 µg/mL.  
 
Scheme 11. Synthesis of toluidine derivatives  
In 2010, a series of 5-(4-isopropylthiazol-2-yl)-4-((E)-((E)-3-phenylallylidene)amino)-4H-
1,2,4-triazole-3-thiol (78; Scheme 12) was synthesized (Kumar et al. 2010).  4-
Isopropylthiazol-2-carbahydrazide 76 was converted into the corresponding 
dithiocarbazinate, which upon cyclization with hydrazine hydrate yields 4-amino-5-(4-
isopropyl-1,3-thiazol-2-yl)-4H-1,2,4-triazole-3-thiol (77). The triazole (77) was condensed 
with 70 in the presence of catalytic amount of H2SO4 in refluxing ethanol to afford 78. 
Synthesized compound 78 was evaluated (Shiradkar et al. 2007; Joshi et al. 2008) for its 
preliminary cytotoxicity and antitubercular activity against M.tb. H37Rv strain by broth 
dilution assay method and showed a promising activity (MIC = 4 µg/mL). 
 
Scheme 12. Synthesis of 2-substituted -5-[isopropylthiazole] clubbed 1,2,4-triazole  
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Scheme 13. Different hydrazone derivatives synthesized from cinnamaldehyde 
Several other hydrazone derivatives (79a-e) of cinnamaldehyde were made and their 
antiTB efficacy was also tested(Scheme 13) (Abdel-Aal et al. 2009). Among them, 
compound 79d, arising from cinnamaldehyde (70) and isoniazid (11), showed maximum 
anti-TB activity (at 50 µg/mL) with the same MIC of the reference drug isoniazid (INH, 
12.5 µg/mL).The synthetic hydrazone (86), exhibiting anti-TB activity (MIC = 25 μg/mL), 
was recently reported by Rao et al. (Scheme 14) (Rao et al., 2010). The authors synthesized 
86 through 3-methyl-2-oxoquinoxalin (82) that is easily obtainable from ortho-
diaminobenzene (80) by refluxing in ethanol along with acetylacetic acid (81). Treatment 
of 82 with 2-chloro ethylacetate (83) in the presence of K2CO3 in DMF gave the 
corresponding ethyl 2-(3-methyl-2-oxoquinoxalin-1(2H)-yl)acetate (84) which was 
converted to 2-(3-methyl-2-oxoquinoxalin-1(2H)-yl)acetohydrazide (85) by refluxing in 
ethanol in the presence of hydrazine hydrate (Scheme 14). Compound 85 was then 
coupled with 70 in DMF in the presence of acetic acid to furnish the desired hydrazone 
(86) which showed anti-TB activity (MIC = 25 μg/mL).  
 
Scheme 14. Synthesis of a quinaxoline-derived cinnamaldehyde hydrazone 
3.3 Cinnamaldehyde-derived metal complexes 
A new series of copper(II) and zinc(II) complexes has been designed and synthesized  using 
a new type of Schiff base (89a-h) derived from the reaction of 3-(3-phenyl-allylidene)-
pentane-2,4-dione (88) with para-substituted aniline and benzene-1,2-dithiol (90) (Scheme 
15) (Raman et al., 2010). The intermediate 88 was first obtained by aldol condensation 
between 70 and acetylacetone (87) using piperidine as base. The minimum inhibitory 
concentrations of the complexes have also been investigated against M.tb. strain H37Rv. The 
lowest MIC values were obtained for -NO2 group containing complexes (91g; MIC = 2.9 
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μg/mL, 91h; MIC = 3.8 μg/mL) which are more active against H37Rv strain than the other 
complexes.  
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Scheme 15. Preparation of Cu(II) and Zn(II) complexes starting from cinnamaldehyde 
4. Chalcone derivatives as anti-TB agents 
Chalcones, one of the major classes of natural products with widespread distribution in 
fruits, vegetables, spices, tea and soya based foodstuffs, are of great interest for their 
interesting pharmacological activities (Di Carlo et al., 1999). Chalcones, or 1,3-diaryl-2-
propen-1-ones, belong to the flavonoid family (Dimmock et al., 1999; Ni et al., 2004). From a 
structural standpoint, they consist of open-chain flavonoids in which the two aromatic rings 
are joined by a three-carbon ǂ,ǃ-unsaturated carbonyl unit (Fig. 8). Interestingly, a vast 
number of naturally occurring chalcones are polyhydroxylated onto both aryl rings 
conferring them significant radical-quenching properties which have raised interest in using 
chalcones or chalcone-rich plant extracts as drugs or food preservatives (Nowakowska, 
2007). Besides, Chalcones have been reported to possess many useful properties, including 
anti-inflammatory, antimicrobial, antifungal, antioxidant, cytotoxic, antitumor and 
anticancer activities (Dimmock et al., 1999; Go, Wu & Liu, 2005).  
4.1 Natural and synthesized chalcones 
M.tb. , M. bovis, M. kansasii, M. xenophii and M. marinum were inhibited by licochalcone A  
(92; MIC = 20 mg /mL), extracted and purified from Chinese licorice roots (Fig. 8) (Friis-
Møller et al. 2002). Besides, the presence of a halogen substituent on A-ring of 2'-
hydroxychalcones proved to play a crucial role on anti-TB activity. It has indeed been found 
that chalcones substituted by a halogen atom at the 3-position demonstrate stronger anti-TB 
activity than those substituted by a halogen atom at the 2- or 4-position (Lin et al., 2002). In 
that manner, chalcones 93 and 94 with a 2'-hydroxyl group on B-ring and a 3-chloro- or 3-
iodo-group on A-ring showed the strongest activity, with 90-92% inhibition against M.tb. 
H37Rv at a drug concentration of 12.5 mg/mL. The activity of 2΄-hydroxychalcone (61% 
inhibition) was further enhanced by introducing a chloro (89%) or a methoxy group (78%) at 
the 4΄-position of B-ring. Nevertheless, introduction of an additional substituent, such as a 
methoxy, amino, bromo or carboxyl group on B-ring led to a dramatic decrease or a 
complete loss of activity (Lin et al., 2002). Recently, the activities of some synthetic chalcones 
were also assayed against M.tb. protein tyrosine phosphatase A (PtpA) which is an enzyme 
associated with M.tb. infectivity (Chiaradia et al., 2008). Note that tyrosine phosphatases are 
secreted by pathogenic bacteria, and MPtpA is an example that was shown to be required 
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for growth of M.tb. in human macrophages (Bach et al., 2008). In the search for lead 
compounds, a series of 38 chalcones were prepared by aldol condensation between 
aldehydes and acetophenones and five of the so-prepared compounds (95-99) presented 
moderate to good activities (Scheme 16). The structure–activity analysis revealed that the 
predominant factor for the activity is the molecular planarity and/or hydrophobicity and 
the nature of the substituents. Later on, the molecular recognition of these inhibitors on 
PtpA was investigated through molecular modeling, these investigations revealing that the 
binding and the inhibitory activity of the chalcones are predominantly governed by the 
positions of the two methoxyl groups at the B-ring (Mascarello et al., 2010). Besides, the –
OMe groups proved to establish key hydrogen bonds with the amino acid residues Arg17, 
His49 and Thr12 in the active site of PtpA while the 2-naphthyl A-ring undergoes л-stacking 
interaction with the Trp48 residue. Interestingly, reduction of mycobacterial survival in 
human macrophages upon inhibitor treatment suggests their potential use as novel 
therapeutics.  
 
Fig. 8. Chalcones with antiTB activities 
 
Scheme 16. General strategy for chalcone synthesis 
4.2 Chalcone hydrazone derivatives 
A series of N΄-nicotinoyl-3-(4΄-hydroxy-3΄-methylphenyl)-5-(substituted phenyl)-2-
pyrazolines (102a-d) were synthesized  by the reaction between isoniazid (INH; 11) and 
chalcones (101a-d) and were tested for their antimycobacterial activity in vitro against M.tb. 
H37Rv and INH-resistant M.tb. (INHR- M.tb.) strains using the agar dilution 
method(Scheme 17) (Shaharyar et al. 2006). Among the synthesized compounds, N΄-
nicotinyl-3-(4΄-hydroxy-3΄-methyl phenyl)-5-(1΄΄-chlorophenyl)-2-pyrazoline (102d) was 
found to be the most active agent against M.tb. and INHR- M.tb., with minimum inhibitory 
concentration of 0.26 µM. When compared to INH-compound 102d was found to be 2.8- and 
43.7-fold more active against M.tb. H37Rv and INHR-M.tb., respectively.  
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Scheme 17. Synthesis and anti-TB activities of chalcone-derived pyrazoline compounds 
4.3 Chalcones with substitutions at the aromatic ring 
A series of acetylenic chalcones were evaluated for antituberculosis activity (Scheme 18) 
(Hans et al., 2010).  The acetylenic functionality not only serves as a site for further chemical 
diversification but is also of great interest in medicinal chemistry and the pharmaceutical 
industry. Moreover, it functions as a key pharmacophoric unit in acetylenic antibiotics 
(Maretina & Trofimov, 2006) and its presence in anticancer (Siddiq & Dembitsky, 2008) and 
antitubercular (Deng et al. 2008) agents is noteworthy. From a synthetic standpoint, 
hydroxyacetophenones (103a,b) were treated with propargyl bromide (104) in the presence 
of K2CO3 in DMF to afford the respective propargyloxyacetophenones (105a,b) that were 
then treated with methoxybenzaldehydes (106,107) under basic conditions to provide the 
chalcones (108a,b) featuring the desired propargyloxy moiety. Most compounds were more 
active against non-replicating (MABA) than replicating (LORA) cultures of M.tb. H37Rv, an 
unusual pattern with respect to existing anti-TB agents.  
 
Scheme 18. Synthesis and anti-TB activities of acetylenic chalcones 
The introduction of a quinoline moiety to chalcones as aromatic substituent was envisaged 
as an interesting way of designing new anti-TB agents. In that manner, a series of 
substituted quinolinyl chalcones (113, 114) was synthesized under basic conditions and 
evaluated for their in vitro anti-TB activity against M.tb. H37Rv (Scheme 19) (Sharma et al., 
2009). The structure–activity relationship analysis revealed that different physicochemical 
and structural requirements are needed for anti-TB activity. Two compounds 113 and 114 
have shown anti-TB activity at MIC 3.12 µg/mL. By comparison, pyrazinamide (115), a 
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known antituberculosis drug, showed a MIC value of 50 µg/mL under similar assay. 
Moreover, these molecules were nontoxic against VERO and MBMDM cell lines.  
 
Scheme 19. Synthesis of substituted quinolinyl chalcones 
4.4 Physico-chemical study  
Importantly, a quantitative structure activity relationship (QSARs) methodology has been 
developed (Sivakumar et al. 2007) for the reported anti-TB activity of chalcones, chalcone-
like compounds, flavones and flavanones using a statistical technique called genetic 
function approximation (GFA). The generated equations in each model were analyzed, for 
both the goodness of fit and predictive capability. The analysis also points out to the 
importance of the hydrogen, PMI-mag and HOMO bond donors. The study indicated that 
the reported compounds are more lipophilic in nature and hence, as expected, exhibit good 
activity since M.tb. has a high concentration of lipid layer. These theoretical models deserve 
to be explored further to design potent, newer compounds having better anti-TB activity. 
5. Conclusion  
Cinnamic acids, cinnamaldehydes and chalcones are unique as drug candidates in 
tuberculosis. Natural cinnamic-based substances such as ethyl- (2) and benzyl- (4) 
cinnamates not only have anti-TB activities, they are traditional medicines for hypertension 
as well.  Cinnamaldehyde and Licochalcone A also have good potentials as anti-TB agents. 
Sharing a common ǂ,ǃ-unsaturated carbonyl functionality, these molecules offer Michael-
acceptor properties, particularly to the glutathione (GSH) and cystine residues. Although, 
mycobacteria, unlike E.coli, do not prefer the formation of Michael-adduct, the presence of 
the cinnamic moiety certainly increased the anti-TB efficacy on several occasions. 
Importantly, the replacement of the double bond with an isosteric cyclopropyl ring 
decreased the anti-TB efficiency of the triazolophthalazines. On the other hand, introduction 
of cinnamoyl moiety to isoniazid did not significantly alter the trend of biological activity or 
the mode of action. These observations indicate that the anti-TB activity depends not only 
on the ǂ,ǃ-unsaturation but also on the functionalization of the carbonyl part of the 
cinnamoyl derivatives. Several hydrazone derivatives of cinnamaldehyde and chalcones 
have notable anti-TB activities. Importantly, substituents at the benzene ring of the cinnamic 
acids also play a crucial role in the biological activities. Notably, Isoprenyloxy cinnamoyl-
triazolophthalazine derivative (68e) and chalcone derived pyrazoline derivative (102d) 
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showed excellent anti-TB activity against INH-resistant strains. In summary, cinnamic acid, 
cinnamaldehyde and chalcone derivatives are regarded as potent anti-TB agents. 
Surprisingly, in spite of their relevant anti-TB activities, little is still known about the mode 
of action and understanding of the implicated molecular mechanisms. We hope to learn 
more about these versatile molecules and its derivatives in addition to the synthesis of new, 
useful biologically important compounds in the near future.  
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